ORA non-exec adds to stake

published 19 October 2010

An ORA Capital Partners non-exec has invested more than £15,000 in the company.

James Ede-Golightly bought 19,176 shares for his SIPP at 80p each. This takes his stake in AIM-quoted ORA to 199,176 shares.

MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

ORA is an investment company specialising in taking significant stakes in developing companies. It has developed five main businesses: Nanoco, Oxford Advanced Surfaces, Tissue Regenix, Oxford Nutrascience and Obtala Resources. All of these are quoted on AIM. ORA also has a stake in broker Novum Securities.

ORA reported a fall in interim profit from £22.2m to £11.5m in the six months to July 2010. The net asset value fell slightly from £127m to £124.8m having bought back £13.7m worth of shares at 100p each.

Top Director Buys

ORA Capital Partners Ltd. (ORA) Director name: Mr James Ede-GolightlyAmount purchased: 19,176 @ 80.00p Value: £15,341

Top Director Sells

Goodwin Plc (GDWN) Director name: Mr John W GoodwinAmount sold: 12,946 @ 1,230.00p Value: £159,236

Goodwin Plc (GDWN) Director name: Mr Richard S GoodwinAmount sold: 8,478 @ 1,230.00p Value: £104,279

Goodwin Plc (GDWN) Director name: Mr Matthew Stanley GoodwinAmount sold: 6,270 @ 1,230.00p Value: £77,121

MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.